What is the role of fecal lactoferrin testing in differentiating between inflammatory and non-inflammatory causes of chronic diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Fecal Lactoferrin in Differentiating Inflammatory and Non-inflammatory Causes of Chronic Diarrhea

Fecal lactoferrin is a highly effective biomarker for differentiating inflammatory from non-inflammatory causes of chronic diarrhea, with a sensitivity of 79% and specificity of 93% at thresholds of 4.0-7.25 μg/g. 1, 2

Diagnostic Value of Fecal Lactoferrin

Performance Characteristics

  • Fecal lactoferrin has excellent diagnostic accuracy for detecting intestinal inflammation:
    • Sensitivity: 79% (95% CI, 73-84%) 1
    • Specificity: 93% (95% CI, 63-99%) 1
    • Threshold range: 4.0-7.25 μg/g 1, 2
    • 100% specific in ruling out IBS 3

Comparison with Other Inflammatory Markers

  • Fecal lactoferrin performs similarly to fecal calprotectin in identifying intestinal inflammation:

    Biomarker Threshold Sensitivity Specificity
    Fecal Lactoferrin 7.25 μg/g 83% 75%
    Fecal Calprotectin 50 μg/g 81% 87%
    Fecal Calprotectin 150 μg/g 71% 69%
    2
  • Serum inflammatory markers (ESR, CRP) are less sensitive and specific than fecal markers:

    • ESR: sensitivity 0.54-0.78, specificity 0.46-0.95 1
    • CRP: sensitivity 0.73, specificity 0.78 1

Clinical Application

When to Use Fecal Lactoferrin Testing

  • Recommended as a screening tool for inflammatory bowel disease in patients with chronic diarrhea 2
  • Particularly useful when trying to differentiate between:
    • Inflammatory bowel disease (IBD) vs. Irritable bowel syndrome (IBS)
    • Active vs. inactive IBD
    • Inflammatory vs. non-inflammatory causes of diarrhea 1, 2

Interpretation of Results

  • Elevated levels (>7.25 μg/g): Strongly suggestive of inflammatory etiology, particularly IBD 2, 3
  • Normal levels (<7.25 μg/g): Suggest non-inflammatory causes like IBS or functional diarrhea 2, 3

Diagnostic Algorithm

  1. Perform fecal lactoferrin testing in patients with chronic diarrhea
  2. If lactoferrin is elevated (>7.25 μg/g):
    • Rule out infectious causes with stool culture and C. difficile testing
    • Consider colonoscopy with biopsies to confirm IBD or other inflammatory conditions
  3. If lactoferrin is normal (<7.25 μg/g):
    • Non-inflammatory causes like IBS are more likely
    • Consider other diagnostic tests for functional disorders

Advantages and Limitations

Advantages

  • Non-invasive test that can reduce the need for unnecessary endoscopic procedures 3, 4
  • High specificity (93%) means positive results are reliable indicators of inflammation 1
  • Useful for monitoring disease activity in established IBD patients 2, 5

Limitations and Caveats

  • False positives can occur with:
    • NSAID use
    • Colorectal cancer
    • Infectious gastroenteritis
    • Recent colonoscopy or bowel preparation 2
  • Different commercial assays may have varying thresholds and performance 2
  • Not useful for establishing specific infectious causes of diarrhea 2
  • Age-related variations (higher in infants, especially breastfed) 2

Evidence-Based Recommendations

  • The American Gastroenterological Association (AGA) suggests using either fecal calprotectin or fecal lactoferrin to screen for IBD in patients with chronic diarrhea (conditional recommendation, low quality evidence) 2
  • Fecal lactoferrin testing should be considered as part of the initial evaluation of patients with suspected inflammatory diarrhea 1, 2
  • In patients with established IBD, normal lactoferrin levels (<7.25 μg/g) indicate likely remission or minimal inflammation 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.